A Phase III Randomized, Multicenter Trial Comparing Sirolimus/Tacrolimus with Tacrolimus/Methotrexate as Graft-Versus-Host Disease (GVHD) Prophylaxis After HLA-Matched, Related Peripheral Blood Stem Cell Transplantation (BMT CTN 0402)
Parent Study Contact: Alan Howard, email@example.com
Study Type: Clinical Trial
Prepared on May 31, 2012
Consent: Restricted Consent
Consent Restrictions: For protocol use only
Commercial Use Restrictions: No
Collection Type: Proprietary Study - See bottom of this webpage for request information
The primary objective is to compare the rates of 114-day Grades II-IV acute GVHD free survival between patients in the two study arms from the time of randomization using an intent-to-treat analysis.
Interested parties can contact Alan Howard for further details about specimen availability.